Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Open Access
- 21 March 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Hematology & Oncology
- Vol. 5 (1), 1-6
- https://doi.org/10.1186/1756-8722-5-12
Abstract
The ASXL1 gene is one of the most frequently mutated genes in malignant myeloid diseases. The ASXL1 protein belongs to protein complexes involved in the epigenetic regulation of gene expression. ASXL1 mutations are found in myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML). They are generally associated with signs of aggressiveness and poor clinical outcome. Because of this, a systematic determination of ASXL1 mutational status in myeloid malignancies should help in prognosis assessment.Keywords
This publication has 53 references indexed in Scilit:
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemiaNature, 2012
- ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic categoryBlood, 2011
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3APublished by American Society of Hematology ,2011
- Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasmsBlood Cancer Journal, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Additional Sex Comb-like (ASXL) Proteins 1 and 2 Play Opposite Roles in Adipogenesis via Reciprocal Regulation of Peroxisome Proliferator-activated Receptor γJournal of Biological Chemistry, 2011
- Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUBNature, 2010
- Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutationsLeukemia Research, 2010
- Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemiaBlood, 2010
- ASXL1 Represses Retinoic Acid Receptor-mediated Transcription through Associating with HP1 and LSD1Journal of Biological Chemistry, 2010